Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001294939-25-000004
Filing Date
2025-12-29
Accepted
2025-12-29 17:05:06
Documents
2
Period of Report
2025-12-23

Document Format Files

Seq Description Document Type Size
1 form4-12292025_101202.html 4  
1 form4-12292025_101202.xml 4 4026
2 ex24-12292025_101202.htm EX-24 6950
  Complete submission text file 0001294939-25-000004.txt   12460
Mailing Address 4350 EXECUTIVE DRIVE SUITE 325 SAN DIEGO CA 92121
Business Address
Petree Daniel H (Reporting) CIK: 0001294939 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38662 | Film No.: 251609985

Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)